← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2015Last known activity
Jun 15, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (22 distinct, 16 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (23)
- NCT07013838Sponsor investigatorPhase 4Jun 15, 2025
- NCT07013838Lead sponsorPhase 4Jun 15, 2025
- NCT07008196Sponsor investigatorPhase 4Jun 10, 2025
- NCT07008196Lead sponsorPhase 4Jun 10, 2025
- NCT06881290Lead sponsorPhase 1May 19, 2025
- NCT06385093Lead sponsorPhase 4Jun 30, 2024
- NCT05805891Lead sponsorN/ADec 31, 2023
- NCT05916781Lead sponsorPhase 4Jul 1, 2023
- NCT05962840Lead sponsorPhase 4Jun 29, 2023
- NCT05828147Lead sponsorPhase 4May 25, 2023
- NCT05965284Lead sponsorPhase 4Mar 9, 2023
- NCT05749666Lead sponsorPhase 3Jan 20, 2023
- NCT05749666Reponsible party - principal investigatorPhase 3Jan 20, 2023
- NCT05151848Lead sponsorPhase 4Dec 15, 2021
- NCT04737343Lead sponsorN/AJun 30, 2021
Details
- Last known activity
- Jun 15, 2025